RhumbLine Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
|
|||||
|
2025
Q1 | $7.61M | Buy |
|
|||||
|
2024
Q4 | $6.01M | Buy |
|
|||||
|
2024
Q3 | $5.45M | Sell |
|
|||||
|
2024
Q2 | $5.61M | Buy |
|
|||||
|
2024
Q1 | $5.73M | Buy |
|
|||||
|
2023
Q4 | $7.3M | Buy |
|
|||||
|
2023
Q3 | $4.74M | Buy |
|
|||||
|
2023
Q2 | $3.06M | Buy |
|
|||||
|
2023
Q1 | $2.69M | Buy |
|
|||||
|
2022
Q4 | $1.2M | Buy |
|
|||||
|
2022
Q3 | $1.51M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.25M | Sell |
|
|||||
|
2021
Q4 | $2.12M | Sell |
|
|||||
|
2021
Q3 | $6.01M | Buy |
|
|||||
|
2021
Q2 | $7.71M | Buy |
|
|||||
|
2021
Q1 | $6.38M | Buy |
|
|||||
|
2020
Q4 | $6.54M | Buy |
|
|||||
|
2020
Q3 | $3.43M | Sell |
|
|||||
|
2020
Q2 | $3.69M | Buy |
|
|||||
|
2020
Q1 | $3.05M | Buy |
|
|||||
|
2019
Q4 | $989K | Buy |
|
|||||
|
2019
Q3 | $527K | Buy |
|